Connection

David Cole to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications David Cole has written about Drug Evaluation, Preclinical.
David Cole
Connection Strength
0.074
Drug Evaluation, Preclinical
  1. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Mol Ther. 2006 Feb; 13(2):357-65.
    View in: PubMed
    Score: 0.060
  2. Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage. J Trauma. 2004 Jul; 57(1 Suppl):S29-32.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.